India's Hetero Labs said on Friday it sought emergency use nod from the local regulator for Merck's COVID-19 drug molnupiravir, after interim data from a late-stage trial showed it helped reduce...
from NDTV News - Topstories https://ift.tt/3qY1aOv
https://ift.tt/eA8V8J
Friday, July 9, 2021
Home »
» Reduces Hospitalisation, Says Merck Of COVID-19 Drug, Seeks India's Ok
0 comments:
Post a Comment